BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27059440)

  • 21. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
    Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
    Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic docking and electron transfer between Zn-myoglobin and cytochrome b(5).
    Liang ZX; Nocek JM; Huang K; Hayes RT; Kurnikov IV; Beratan DN; Hoffman BM
    J Am Chem Soc; 2002 Jun; 124(24):6849-59. PubMed ID: 12059205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient Reduction of Vertebrate Cytoglobins by the Cytochrome b
    Amdahl MB; Sparacino-Watkins CE; Corti P; Gladwin MT; Tejero J
    Biochemistry; 2017 Aug; 56(30):3993-4004. PubMed ID: 28671819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of apo-cytochrome b5 utilizing heme transfer to apo-myoglobin.
    Mrazova B; Martinek V; Martinkova M; Sulc M; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():72-9. PubMed ID: 20027148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site.
    Bewley MC; Davis CA; Marohnic CC; Taormina D; Barber MJ
    Biochemistry; 2003 Nov; 42(45):13145-51. PubMed ID: 14609324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of mutation at Glu44 and Glu56 of cytochrome b5 on the protein's stabilization and interaction between cytochrome c and cytochrome b5.
    Qian W; Sun YL; Wang YH; Zhuang JH; Xie Y; Huang ZX
    Biochemistry; 1998 Oct; 37(40):14137-50. PubMed ID: 9760250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and mechanistic roles of three consecutive Pro residues of porcine NADH-cytochrome b(5) reductase for the binding of beta-NADH.
    Nishimura Y; Shibuya M; Muraki A; Takeuchi F; Park SY; Tsubaki M
    J Biosci Bioeng; 2009 Oct; 108(4):286-92. PubMed ID: 19716516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytochrome b5 reductase: structure, function, and potential applications.
    Elahian F; Sepehrizadeh Z; Moghimi B; Mirzaei SA
    Crit Rev Biotechnol; 2014 Jun; 34(2):134-43. PubMed ID: 23113554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulation study on stabilities and reactivities of NADH cytochrome B5 reductase.
    Asada T; Nagase S; Nishimoto K; Koseki S
    J Phys Chem B; 2008 May; 112(18):5718-27. PubMed ID: 18412408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the differences between rat liver outer mitochondrial membrane cytochrome b5 and microsomal cytochromes b5.
    Altuve A; Silchenko S; Lee KH; Kuczera K; Terzyan S; Zhang X; Benson DR; Rivera M
    Biochemistry; 2001 Aug; 40(32):9469-83. PubMed ID: 11583146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.
    Zhang H; Gruenke L; Arscott D; Shen A; Kasper C; Harris DL; Glavanovich M; Johnson R; Waskell L
    Biochemistry; 2003 Oct; 42(40):11594-603. PubMed ID: 14529269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologous expression and mechanistic investigation of a fungal cytochrome P450 (CYP5150A2): involvement of alternative redox partners.
    Ichinose H; Wariishi H
    Arch Biochem Biophys; 2012 Feb; 518(1):8-15. PubMed ID: 22206618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and Molecular Mechanism of a Novel Cytochrome
    Cui J; Chen H; Tang X; Zhang H; Chen YQ; Chen W
    J Agric Food Chem; 2022 Apr; 70(16):5186-5196. PubMed ID: 35416034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.
    Deng B; Parthasarathy S; Wang W; Gibney BR; Battaile KP; Lovell S; Benson DR; Zhu H
    J Biol Chem; 2010 Sep; 285(39):30181-91. PubMed ID: 20630863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of electron transfer in fusion protein cytochrome b5-NADH-cytochrome b5 reductase.
    Yantsevich AV; Gilep AA; Usanov SA
    Biochemistry (Mosc); 2008 Oct; 73(10):1096-107. PubMed ID: 18991555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic engineering of redox donor sites: measurement of intracomplex electron transfer between ruthenium-65-cytochrome b5 and cytochrome c.
    Willie A; Stayton PS; Sligar SG; Durham B; Millett F
    Biochemistry; 1992 Aug; 31(32):7237-42. PubMed ID: 1324708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the covalent cross-links of the active sites of amidinated cytochrome b5 and NADH:cytochrome b5 reductase.
    Strittmatter P; Hackett CS; Korza G; Ozols J
    J Biol Chem; 1990 Dec; 265(35):21709-13. PubMed ID: 2123873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.
    Zhu H; Qiu H; Yoon HW; Huang S; Bunn HF
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14742-7. PubMed ID: 10611283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
    Locuson CW; Wienkers LC; Jones JP; Tracy TS
    Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrostatic redesign of the [myoglobin, cytochrome b5] interface to create a well-defined docked complex with rapid interprotein electron transfer.
    Xiong P; Nocek JM; Griffin AK; Wang J; Hoffman BM
    J Am Chem Soc; 2009 May; 131(20):6938-9. PubMed ID: 19419145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.